Issue 32, 2011

Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

Abstract

A platform protocol developed based on the hollow manganese oxide nanoparticles provided multimodal diagnostic agents, which allow the selectively detect vulva cancer with T1-weighted in vivo MRI.

Graphical abstract: Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

Supplementary files

Article information

Article type
Communication
Submitted
20 May 2011
Accepted
27 Jun 2011
First published
15 Jul 2011

Chem. Commun., 2011,47, 9176-9178

Development of target-specific multimodality imaging agent by using hollow manganese oxide nanoparticles as a platform

T. Ha, H. J. Kim, J. Shin, G. H. Im, J. W. Lee, H. Heo, J. Yang, C. M. Kang, Y. S. Choe, J. H. Lee and I. S. Lee, Chem. Commun., 2011, 47, 9176 DOI: 10.1039/C1CC12961A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements